Hopkins in the news
Commentary: mRNA technology has cancer in its sights
Published Nov 11, 2025'With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough,' writes Johns Hopkins expert Jeff Coller in a 'Wall Street Journal' op-ed